US sends Ebola drug to DRC for outbreak trials
SowetanliveWednesday, June 24, 2026
The US has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials to fight the widening Ebola outbreak in the Democratic Republic of the Congo, a health department spokesperson says.
Primary Scripture
Community launching soon
Get the invite by email when the Watchman's Wall opens
Share this article
Source: Sowetanlive— we link to the original for full context.